BioSenic S.A.
BIOS.BR · BRU
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €0 | €0 | €2,694 | €178 |
| % Growth | – | -100% | 1,413.5% | – |
| Cost of Goods Sold | €0 | €93 | €106 | €266 |
| Gross Profit | €0 | -€93 | €2,694 | -€88 |
| % Margin | – | – | 100% | -49.4% |
| R&D Expenses | €28 | €668 | €1,539 | €1,479 |
| G&A Expenses | €0 | €0 | €1,532 | €1,838 |
| SG&A Expenses | €381 | €4,351 | €1,518 | €1,838 |
| Sales & Mktg Exp. | €0 | €0 | -€14 | €0 |
| Other Operating Expenses | €0 | €0 | €104 | -€134 |
| Operating Expenses | €409 | €5,019 | €3,161 | €3,183 |
| Operating Income | -€409 | -€5,112 | -€467 | -€3,316 |
| % Margin | – | – | -17.3% | -1,862.9% |
| Other Income/Exp. Net | -€303 | -€1,946 | €816 | -€4,649 |
| Pre-Tax Income | -€712 | -€7,058 | €349 | -€7,965 |
| Tax Expense | €0 | €0 | -€349 | -€31 |
| Net Income | -€712 | -€5,263 | €495 | -€7,935 |
| % Margin | – | – | 18.4% | -4,457.9% |
| EPS | -0.001 | -0.016 | 0.25 | -0.053 |
| % Growth | 93.2% | -106.5% | 571.7% | – |
| EPS Diluted | -0.001 | -0.016 | 0.25 | -0.053 |
| Weighted Avg Shares Out | 652,862 | 323,932 | 1,957 | 149,582 |
| Weighted Avg Shares Out Dil | 652,862 | 323,932 | 1,957 | 149,581 |
| Supplemental Information | – | – | – | – |
| Interest Income | €1 | €33 | €24 | €58 |
| Interest Expense | €4 | €1,439 | €787 | €9,636 |
| Depreciation & Amortization | €0 | €93 | €106 | €142 |
| EBITDA | -€706 | -€5,526 | -€361 | -€2,996 |
| % Margin | – | – | -13.4% | -1,683.1% |